COVID-19 infection and vaccine status in patients with chronic kidney diseases

M. Shafiul Haider; Marina Arjumand; Syed Mahtab Ul Islam; N. M. Abdul Aziz; M. Hasan Mahmud

doi:10.18203/2320-6012.ijrms20231304

Authors

M. Shafiul Haider Department of Nephrology, Chottogram Medical College Hospital, Chottogram, Bangladesh
Marina Arjumand Department of Nephrology, Chottogram Medical College Hospital, Chottogram, Bangladesh
Syed Mahtab Ul Islam Department of Nephrology, Chottogram Medical College Hospital, Chottogram, Bangladesh
N. M. Abdul Aziz Department of Pharmacy, North South University, Dhaka, Bangladesh
M. Hasan Mahmud Department of Pharmacy, International Islamic University Chittagong, Chittagong, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20231304

Keywords:

Kidney, Infection, COVID-19, CKD, Vaccination

Abstract

Background: The COVID-19 virus has had a great effect globally, changing many commonalities. The incidence of COVID-19 had weakened the immune system, leading to more severe outcomes of various common diseases. Since its early development, the vaccination of COVID-19 has also had mixed responses. The aim of the study was to observe the incidence rate of COVID-19 infection and vaccination status among chronic kidney disease patients.

Methods: In this study 50 (27 male and 23 female) adult skulls were investigated to determine the type of asterion, its distance from important bony landmarks and also the nearby venous sinuses were measured.

Results: Majority (41.61%) of the participants had been between the ages of 41-55 years old, and 64.84% male prevalence was observed. 60.65% of the participants had been from rural areas. A large portion of the participants (38.06%) did not have any comorbidities, while multiple comorbidities were present among many of the remaining participants. Hypertension was the most common comorbidity, observed in 56.45% of the participants. 72.26% of the present study participants had been asymptomatic, while 13.23% had a fever as their symptom of COVID-19. COVID-19 test was done on 81 patients, among whom 64 had tested positive. Among the total 310 participants, 29.03% had not received any vaccinations, while 14.19% had received only 1st dose of vaccination, 47.2% had received up to their 2nd dose, and 9.35% had received their booster dose.

Conclusions: The present study observed a low incidence rate of COVID-19 positive patients among those affected by chronic kidney disease. However, the study also observed a significant positive relation between COVID-19 positive patients and the need for additional medical support, leading to the conclusion that COVID-19 can significantly affect the severity of CKD.

Metrics

Metrics Loading ...

References

Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduct Target Ther. 2020;5(1):128.

Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953-66.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

Google News. Coronavirus (COVID-19), 2022. Available at: https://news.google.com/COVID-19. Accessed on 04 February 2023.

Mahase E. Covid-19: What do we know about "long covid"? BMJ. 2020;370:m2815.

Naja F, Hamadeh R. Nutrition amid the COVID-19 pandemic: a multi-level framework for action. Eur J Clin Nutr. 2020;74(8):1117-21. Boissay F, Rungcharoenkitkul P. Macroeconomic effects of COVID-19: an early review. Bank for International Settlements; 2020 Apr 17.

Boissay F, Rungcharoenkitkul P. Macroeconomic effects of COVID-19: an early review. Bank Int Settlem. 2020.

Clemmensen C, Petersen MB, Sørensen TIA. Will the COVID-19 pandemic worsen the obesity epidemic? Nat Rev Endocrinol. 2020;16(9):469-70.

ReliefWeb. The Emergence of 2 New SARS-CoV-2 Omicron Subvariants in Dhaka City, 2022. Available at: https://reliefweb.int/report/bangladesh/eme. Accessed on 04 February 2023.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81.

Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020;97(5):824-8.

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38.

Li Z, Wu M, Yao J, Guo J, Liao X, Song S, et al. Caution on kidney dysfunctions of COVID-19 patients. SSRN Electron J. 2022.

ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021;36(1):87-94.

Windpessl M, Bruchfeld A, Anders H-J, Kramer H, Waldman M, Renia L, et al. COVID-19 vaccines and kidney disease. Nat Rev Nephrol. 2021;17(5):291-3.

National Kidney Foundation. Kidney disease and COVID-19, 2022. Available at: https://www.kidney.org/coronavirus/kidney-disease-COVID-19. Accessed on 04 February 2023.

Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020;8(8):e1003-17.

Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet. 2012 Dec 15;380(9859):2055-8.

Peter WL, Khan SS, Ebben JP, Pereira BJ, Collins AJ. Chronic kidney disease: the distribution of health care dollars. Kidney Int. 2004;66(1):313-21.

Tonelli M, Riella M. Chronic kidney disease and the aging population. J Nephrol. 2014;27(1):1-5.

Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27(3):363-73.

Rao AS, Phaneendra D, Pavani ChD, Soundararajan P, Rani NV, Thennarasu P, et al. Usage of complementary and alternative medicine among patients with chronic kidney disease on maintenance hemodialysis. J Pharm Bioallied Sci. 2016;8(1):52-7.

Horowitz B, Miskulin D, Zager P. Epidemiology of hypertension in CKD. Adv Chronic Kidney Dis. 2015;22(2):88-95.

Williams ME. Diabetic CKD/ESRD 2010: a progress report?. Seminars in dialysis. Oxford, UK: Blackwell Publishing Ltd; 2010: 129-133.

Carlson N, Nelveg-Kristensen KE, Freese Ballegaard E, Feldt-Rasmussen B, Hornum M, Kamper AL, et al. Increased vulnerability to COVID-19 in chronic kidney disease. J Intern Med. 2021;290(1):166-78.

Pecly IMD, Azevedo RB, Muxfeldt ES, Botelho BG, Albuquerque GG, Diniz PHP, et al. COVID-19 and chronic kidney disease: a comprehensive review. J Bras Nefrol. 2021;43(3):383-99.

Podestà MA, Valli F, Galassi A, Cassia MA, Ciceri P, Barbieri L, et al. COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors. Blood Purif. 2021;50(6):740-9.